CNBC’s Jim Cramer on Thursday lamented the negative sentiment surrounding the economy, which he thinks the White House is ...

During the latest episode of Mad Money, Jim Cramer focused on the recent market volatility and the reasons behind it.

CNBC's Jim Cramer opined on how President Donald Trump helped cause Monday's intense decline, suggesting investors are ...

We recently published a list of Jim Cramer Discusses These 13 Stocks & Criticizes Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against ...

We recently published a list of Jim Cramer Discusses These 14 Stocks & Zero Day Options. In this article, we are going to take a look at where Lowe’s Companies, Inc. (NYSE:LOW) stands against ...

We recently compiled a list of the 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where AerCap Holdings N.V. (NYSE:AER) stands against the other stocks on Jim ...

We recently compiled a list of the Jim Cramer and Analysts Like These 10 Stocks. In this article, we are going to take a look at where Twilio Inc. (NYSE:TWLO) stands against the other stocks.

We recently published a list of Jim Cramer Discusses These 13 Stocks & Criticizes Billionaires. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against ...

We recently published a list of Jim Cramer Discusses These 14 Stocks & Zero Day Options. In this article, we are going to take a look at where General Motors Company (NYSE:GM) stands against other ...

We recently published a list of Jim Cramer’s Latest Portfolio: Top 10 Stocks to Watch. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against other top ...

We recently published a list of Jim Cramer Discusses These 14 Stocks & Zero Day Options. In this article, we are going to take a look at where Sempra (NYSE:SRE) stands against other stocks that ...

We recently published a list of Jim Cramer’s Latest Portfolio: Top 10 Stocks to Watch.In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against ...